Pancreatic Cancer Research

ResearcherChina Three Gorges UniversityNo recent work listed

Jun Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0679-6962; OpenAlex author ID A5101407606. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. High KLK7 Expression Predicts Unfavorable Outcomes in Patients with Resectable Pancreatic Ductal Adenocarcinoma Last author DOI 10.21203/rs.3.rs-985162/v1↗
  2. Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer. Co-author DOI 10.18632/oncotarget.24132↗
  3. Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer. Last author DOI 10.3892/ol.2014.2751↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rucheng Yao · 1 shared paper, 2021 · strength 0.14
  2. Jun X. Hu · 1 shared paper, 2021 · strength 0.14
  3. Jian Ping Du · 1 shared paper, 2018 · strength 0.08
  4. Wei Liu · 1 shared paper, 2018 · strength 0.08
  5. Xiao Tan · 1 shared paper, 2018 · strength 0.08
  6. Zheng He · 1 shared paper, 2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.